New pricing criteria of chemically modified medicines draw positive reactions

The government plans to set a new pricing standard for chemically modified drugs in the latter half of this year, under consultation with the Korea Pharmaceutical Manufacturers Association, according to the Ministry of Health, Welfare and Family Affairs.

Under the plan, the government will unilaterally decide the price of chemically modified medicines without negotiations with pharmaceutical...